- Survival of patients as a function of MSKCC scores for sunitinib treatment in the 1st mRCC treatment line2019 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Analysis of 2390 Patients2020 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Interdisciplinary approach to the treatment of renal clear acell carcinoma2017 | Publication without faculty affiliation
- Immunotherapy of Renal Cell Carcinoma2017 | First Faculty of Medicine
- Comparison of Two Prognostic Models in Patients with Metastatic Renal Cancer Treated with Sunitinib: a Retrospective, Registry-Based Study2015 | First Faculty of Medicine
- Current status of nephrectomy in the treatment of metastatic renal cell carcinoma2023 | Faculty of Medicine in Hradec Králové
- Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer2015 | Second Faculty of Medicine
- Cytoreductive nephrectomy and overall survival of patients with metastatic renal cell carcinoma treated with targeted therapy-data from the national renis registry2020 | First Faculty of Medicine
- Cytoreductive Nephrectomy and Overall Survival of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy-Data from the National Renis Registry2020 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University
